NewAmsterdam Pharma Company N.V. Ordinary Shares
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
NewAmsterdam Pharma Company N.V. Ordinary Shares Company Information, Fundamentals, and Technical Indicators
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
NewAmsterdam Pharma Company N.V. Ordinary Shares In Our Stock Scanner
As of Aug 14, 2025Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.